Matthew W. Towse, SVP and Chief Financial Office at NxStage Medical, Inc. (NXTM), sold 6,944 shares at $20.40 ($142K) on 2016-01-11, disclosed to the SEC on 2016-01-11.
Open-market sale of $142k NXTM by SVP and Chief Financial Office. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.40 | 3,472 | $71K | 50.0% |
| 2 | $20.40 | 3,472 | $71K | 50.0% |
| Total | $20.40 avg | 6,944 | $142K | 100% |
| Filing → |
| NXTM | SELL | 2017-08-23 | $126K | — | Filing → |
| NXTM | SELL | 2017-07-21 | $104K | — | Filing → |
| NXTM | SELL | 2017-06-21 | $100K | — | Filing → |